Recombinant CD79B (Polatuzumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- Target
- CD79B (Polatuzumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Humanized
- Expression System
- Mammalian cells
-
Clonality
- Chimeric
-
Conjugate
- This CD79B (Polatuzumab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Research Grade Polatuzumab Biosimilar Antibody
- Specificity
- B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b
- Purification
- Protein A or G purified from cell culture supernatant.
- Purity
- >95 % by SDS-PAGE.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-CD79B (Polatuzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Expiry Date
- 12 months
-
- Target
- CD79B (Polatuzumab Biosimilar)
- Alternative Name
- Polatuzumab Biosimilar
- Target Type
- Biosimilar
- Background
- B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b
- UniProt
- P40259
- CAS-No
- 1313206-42-6
-
You are here:
